NVDA

200.95

+4.96%↑

AVGO.US

372.76

+2.87%↑

TSM

301.77

+1.15%↑

ORCL

280.65

-0.18%↓

ASML.US

1,051.93

-0.77%↓

NVDA

200.95

+4.96%↑

AVGO.US

372.76

+2.87%↑

TSM

301.77

+1.15%↑

ORCL

280.65

-0.18%↓

ASML.US

1,051.93

-0.77%↓

NVDA

200.95

+4.96%↑

AVGO.US

372.76

+2.87%↑

TSM

301.77

+1.15%↑

ORCL

280.65

-0.18%↓

ASML.US

1,051.93

-0.77%↓

NVDA

200.95

+4.96%↑

AVGO.US

372.76

+2.87%↑

TSM

301.77

+1.15%↑

ORCL

280.65

-0.18%↓

ASML.US

1,051.93

-0.77%↓

NVDA

200.95

+4.96%↑

AVGO.US

372.76

+2.87%↑

TSM

301.77

+1.15%↑

ORCL

280.65

-0.18%↓

ASML.US

1,051.93

-0.77%↓

Search

SS&C Technologies Holdings Inc

Slēgts

SektorsTehnoloģijas

85.07 -0.46

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

84.52

Max

85.87

Galvenie mērījumi

By Trading Economics

Ienākumi

30M

211M

Pārdošana

31M

1.6B

P/E

Sektora vidējais

25.132

82.63

EPS

1.57

Dividenžu ienesīgums

1.21

Peļņas marža

13.438

Darbinieki

26,800

EBITDA

14M

534M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+20.88% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

1.21%

2.67%

Nākamais Ex dividenžu datums

2025. g. 1. dec.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

992M

21B

Iepriekšējā atvēršanas cena

85.53

Iepriekšējā slēgšanas cena

85.07

Ziņu noskaņojums

By Acuity

50%

50%

185 / 407 Rangs Technology

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

SS&C Technologies Holdings Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 28. okt. 23:50 UTC

Karstas akcijas

Stocks to Watch: Caesars, Enphase, Mondelez, Teradyne

2025. g. 28. okt. 23:25 UTC

Peļņas

SK Hynix Posts Record Earnings on Continued AI-Chip Demand

2025. g. 28. okt. 23:18 UTC

Peļņas

Booking 3Q Sales Rise as U.S. Travel Demand Stabilizes -- Update

2025. g. 28. okt. 22:20 UTC

Peļņas

Visa Sales Jump as Consumers Keep Spending -- 2nd Update

2025. g. 28. okt. 22:13 UTC

Peļņas

Wal-Mart de Mexico Net Profit Falls in 3Q

2025. g. 28. okt. 21:38 UTC

Peļņas

Correction to Visa Sales Jump Article

2025. g. 28. okt. 21:17 UTC

Peļņas

OrthoPediatrics Wins FDA Approval for Surgery Plating System; 3Q Revenue Rises

2025. g. 28. okt. 21:07 UTC

Peļņas

Visa Sales Jump as Consumers Keep Spending -- Update

2025. g. 28. okt. 21:02 UTC

Peļņas

Mondelez Tempers Outlook as Costs Rise

2025. g. 28. okt. 23:51 UTC

Tirgus saruna

Nikkei May Rise on Easing U.S.-China Tensions -- Market Talk

2025. g. 28. okt. 23:42 UTC

Tirgus saruna

Gold Edges Lower on Possible Position Adjustments Ahead of FOMC Decision -- Market Talk

2025. g. 28. okt. 23:02 UTC

Peļņas

SK Hynix: HBM4 Shipments to Start in 4Q, Ahead of Full-Scale Sales Expansion in 2026

2025. g. 28. okt. 23:01 UTC

Peļņas

SK Hynix: Completed Discussions With Key Customers About 2026 HMB Supply

2025. g. 28. okt. 22:46 UTC

Peļņas

SK Hynix: Co. Secured Full Customer Demand for Its Entire DRAM and NAND Production for Next Yr >000660.SE

2025. g. 28. okt. 22:45 UTC

Peļņas

SK Hynix 3Q Net KRW12.6T >000660.SE

2025. g. 28. okt. 22:44 UTC

Peļņas

SK Hynix 3Q Rev KRW24.44T >000660.SE

2025. g. 28. okt. 22:43 UTC

Peļņas

SK Hynix 3Q Net Profit Beat FactSet-Compiled Consensus

2025. g. 28. okt. 22:42 UTC

Peļņas

SK Hynix 3Q Net KRW12.598T Vs. Net KRW5.753T >000660.SE

2025. g. 28. okt. 22:40 UTC

Peļņas

SK Hynix 3Q Rev KRW24.449T Vs. KRW17.573T >000660.SE

2025. g. 28. okt. 22:40 UTC

Peļņas

SK Hynix 3Q Oper Pft KRW11.383T Vs. Pft KRW7.030T >000660.SE

2025. g. 28. okt. 22:22 UTC

Peļņas

Pharmaron Beijing: Higher Contributions From Clinical-Development Services Supported Results >300759.SZ

2025. g. 28. okt. 22:22 UTC

Peļņas

Pharmaron Beijing: Higher Contributions From Laboratory Services Supported Results >300759.SZ

2025. g. 28. okt. 22:22 UTC

Peļņas

Pharmaron Beijing 3Q Net CNY439.52M, Up 42.5% on Year >300759.SZ

2025. g. 28. okt. 22:20 UTC

Peļņas

Pharmaron Beijing 3Q Rev CNY3.64B, Up 13.4% on Year >300759.SZ

2025. g. 28. okt. 22:02 UTC

Peļņas

Review & Preview: Earnings Extravaganza -- Barrons.com

2025. g. 28. okt. 21:42 UTC

Tirgus saruna
Peļņas

Global Equities Roundup: Market Talk

2025. g. 28. okt. 21:42 UTC

Tirgus saruna
Peļņas

Mondelez Says Cocoa Costs Peaked Heading Into Spooky Season -- Market Talk

2025. g. 28. okt. 21:20 UTC

Peļņas

Wal-Mart de Mexico 3Q EBITDA MXN25.27B, Up 3.3% on Year

2025. g. 28. okt. 21:19 UTC

Peļņas

Wal-Mart de Mexico 3Q Rev MXN241.52B, Up 4.9% on Year

2025. g. 28. okt. 21:18 UTC

Peļņas

Wal-Mart de Mexico 3Q Net MXN11.75B, Down 9.2% on Year

Salīdzinājums

Cenas izmaiņa

SS&C Technologies Holdings Inc Prognoze

Cenas mērķis

By TipRanks

20.88% augšup

Prognoze 12 mēnešiem

Vidējais 103.29 USD  20.88%

Augstākais 112 USD

Zemākais 92 USD

Pamatojoties uz 9 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi SS&C Technologies Holdings Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

9 ratings

8

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

75.15 / 78.1Atbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Strong Bearish Evidence

Ilgtermiņā

Strong Bullish Evidence

Noskaņojums

By Acuity

185 / 407 Rangs Tehnoloģijas

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Vidējais

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par SS&C Technologies Holdings Inc

SS&C Technologies Holdings, Inc., together with its subsidiaries, provides software products and software-enabled services to financial services and healthcare industries. The company owns and operates technology stack across securities accounting; front-office functions, such as trading and modeling; middle-office functions comprising portfolio management and reporting; back-office functions, such as accounting, performance measurement, reconciliation, reporting, processing and clearing, and compliance and tax reporting; and healthcare solutions consisting of claims adjudication, benefit management, care management, and business intelligence solutions. Its products and services allow professionals in the financial services and healthcare industries to automate complex business processes and are instrumental in helping its clients to manage information processing requirements. The company's software-enabled services include SS&C GlobeOp, Global Investor and Distribution Solutions, SS&C Retirement Solutions, Black Diamond Wealth Platform, CRM Solutions, Advent Managed Services, Advent Data Solutions, ALPS Advisors, and Virtual Data Rooms, as well as pharmacy, healthcare administration, and health outcomes optimization solutions. Its software products comprise portfolio/investment accounting and analytics software, portfolio management software, trading software, automation solutions, and banking and lending solutions, as well as research, analytics, risk, and training solutions. The company also provides professional services that includes consulting and implementation services consisting of initial system installation, conversion of historical data, and ongoing training and support, as well as product support services. It operates in the United States; Europe, the Middle East, and Africa; the Asia Pacific and Japan; Canada; and the Americas. The company was founded in 1986 and is headquartered in Windsor, Connecticut.
help-icon Live chat